Search
What are you looking for?
Start main content

Chairpersons of Departments

Chairpersons of Departments

https://www.med.cuhk.edu.hk/staff/professor-tse-man-kit-gary
https://www.med.cuhk.edu.hk/staff/professor-tse-man-kit-gary
Professor TSE Man Kit, Gary

Professor TSE Man Kit, Gary

Chairman, Department of Anatomical and Cellular Pathology

CUHK Employment
  • Chairman and Professor, Department of Anatomical and Cellular Pathology

 

Expertise
  • Breast Pathology

 

Education & Qualifications

MBBS(HK), FRCPC, FCAP, DAB(AP), FRCPath

 

 

Research Interests
  • Molecular basis of morphological features in breast cancers
  • Diagnostic and prognostic markers in breast cancers
  • Pathogenesis and diagnosis of breast lesions (fibroepithelial lesions, papillary lesions) 
  • Cytopathology of breast diseases 

 

Additional Information

 

Professional Service

  • Honorary Chief of Service, Department of Pathology, Alice Ho Miu Ling Nethersole Hospital
  • Honorary Chief of Service, Department of Pathology, North District Hospital
  • Honorary Consultant, New Territories East Cluster

 

Selected Publications

 

  1. Li Y, Tsang JY, Tam F, Loong T, Tse GM. Comprehensive characterization of HER2-low breast cancers: implications in prognosis and treatment. EBioMedicine.2023 May;91:104571. 
  2. Ellis IO, Rakha EA, Tse GM, Tan PH. An international unified approach to reporting and grading invasive breast cancer. An overview of the International Collaboration on Cancer Reporting (ICCR) initiative. Histopathology. 2023 Jan;82(1):189-197
  3. Tsang JY, Shao Y, Poon IK, Ni YB, Kwan JS, Chow C, Shea KH, Tse GM. Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis. Pathology. 2022 Oct;54(6):678-685.
  4. Ni Y, Tsang JY, Shao Y, Poon IK, Tam F, Shea KH, Tse GM. Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of Breast Cancer Subtypes. Oncologist. 2022 Apr 5;27(4):e313-e327.
  5. Thennavan A, Beca F, Xia Y, Recio SG, Allison K, Collins LC, Tse GM, Chen YY, Schnitt SJ, Hoadley KA, Beck A, Perou CM. Molecular analysis of TCGA breast cancer histologic types. Cell Genom. 2021 Dec 8;1(3):100067. 
  6. Poon IK, Tsang JY, Li J, Chan SK, Shea KH, Tse GM. The significance of highlighting the oestrogen receptor low category in breast cancer. Br J Cancer. 2020 Oct;123(8):1223-1227.
  7. Lai BS, Tsang JY, Poon IK, Shao Y, Chan SK, Tam FK, Cheung SY, Shea KH, Tse GM. The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas. Oncologist. 2020 Sep;25(9):e1318-e1329. 
  8. Tsang JY, Ho CS, Ni YB, Shao Y, Poon IK, Chan SK, Cheung SY, Shea KH, Marabi M, Tse GM. Co-expression of HLA-I loci improved prognostication in HER2+ breast cancers. Cancer Immunol Immunother. 2020 May;69(5):799-811. 
  9. Liu X, Tsang JYS, Hlaing T, Hu J, Ni YB, Chan SK, Cheung SY, Tse GM. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers. Oncologist. 2017 Nov;22(11):1316-1324.
  10. Heng YJ, Lester SC, Tse GM, Factor RE, Allison KH, Collins LC, Chen YY, Jensen KC,  Johnson NB, Jeong JC, Punjabi R, Shin SJ, Singh K, Krings G, Eberhard DA, Tan PH, Korski K, Waldman FM, Gutman DA, Sanders M, Reis-Filho JS, Flanagan SR, Gendoo DM, Chen GM, Haibe-Kains B, Ciriello G, Hoadley KA, Perou CM, Beck AH. The molecular basis of breast cancer pathological phenotypes. J Pathol. 2017 Feb;241(3):375-391.